SCHEMBL60610

SCHEMBL60610

CCCCCCC1=CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
ALOX15 P16050 2/20 0.46
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
RAB9A P51151 1/20 0.40
USP2 O75604 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
LMNA P02545 2/20 0.38
ESR1 P03372 2/20 0.38
ADRA2A P08913 2/20 0.38
ADORA3 P0DMS8 2/20 0.38
TACR2 P21452 2/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 2/20 0.38
KDM4E B2RXH2 1/20 0.38
SHBG P04278 1/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
HSPD1 P10809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28861193 1.00 ALDH1A1 (0.46) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A
SCHEMBL61669 1.00 ALDH1A1 (0.46) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A
SCHEMBL7459531 1.00 ALDH1A1 (0.46) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A
SCHEMBL9213508 1.00 ALDH1A1 (0.46) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A
SCHEMBL6839659 1.00 ALDH1A1 (0.46) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A
SCHEMBL11069335 0.98 ALDH1A1 (0.45) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A
SCHEMBL11069331 0.98 ALDH1A1 (0.45) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A
SCHEMBL28336524 0.98 ALDH1A1 (0.45) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A
SCHEMBL17768658 0.98 ALDH1A1 (0.45) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A
SCHEMBL29212867 0.98 ALDH1A1 (0.45) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109806863-A The preparation of Au catalyst and its application in oxidative dehydrogenation of cyclonexane reaction 中国科学院大连化学物理研究所 2019-05-28 CN claimed
CN-1201182-C Liquid crystal display contg. chiral dopant MERCK PATENT GMBH (DE) 2005-05-11 CN claimed
CN-1420382-A Liquid crystal display contg. chiral dopant MERCK PATENT GMBH (DE) 2003-05-28 CN claimed
US-12370135-B2 Anhydrous composition for caring for and/or making up keratin materials L'OREAL (FR) 2025-07-29 US disclosed
CN-115484927-B Method for producing hydrophilic organopolysiloxane gels 瓦克化学股份公司 2024-08-20 CN disclosed
CN-110366551-B Compound, coating composition comprising the same, and organic light-emitting element comprising the same 株式会社LG化学 2023-12-08 CN disclosed
US-20230331919-A1 METHOD FOR PRODUCING HYDROPHILIC ORGANOPOLYSILOXANE GELS WACKER CHEMIE AG (DE) 2023-10-19 US disclosed
US-20230218633-A1 METHODS OF TREATING ORAL MUCOSITIS GALERA LABS, LLC 2023-07-13 US disclosed
CN-116143660-A Compound, curing agent composition, resin composition, coating composition, and resin cured product 旭化成株式会社 2023-05-23 CN disclosed
US-11612608-B2 Methods of treating oral mucositis GALERA LABS, LLC (US) 2023-03-28 US disclosed
CN-109863133-B Fluorene-based compound, organic light emitting device using the same, and method of manufacturing the same 株式会社LG化学 2022-12-23 CN disclosed
EP-0441951-A1 HALOGENATED BENZENE DERIVATIVES AND LIQUID CRYSTALLINE MEDIUM. MERCK PATENT GMBH (DE) 1991-08-21 EP disclosed
EP-0441940-A1 PHENYLCYCLOHEXANES AND LIQUID CRYSTAL MEDIUM. MERCK PATENT GMBH (DE) 1991-08-21 EP disclosed
EP-0437595-A1 FLUORO-CHLORO-BENZENE DERIVATIVES. MERCK PATENT GMBH (DE) 1991-07-24 EP disclosed
EP-0421441-A2 Pantothenic acid derivatives FUJIREBIO INC. (JP) 1991-04-10 EP disclosed
WO-1991003445-A2 HALOGENATED BENZENE DERIVATIVES AND LIQUID CRYSTALLINE MEDIUM MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-03-21 WO disclosed
WO-1991002043-A1 FLUORO-CHLORO-BENZENE DERIVATIVES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-02-21 WO disclosed
CN-1037334-A Pyridine derivate MERCK PATENT GMBH (DE) 1989-11-22 CN disclosed
US-4252707-A AMINE SALT, WATER-THINNABLE RUID JOHN O 1981-02-24 US disclosed
US-4025353-A CELLULOSE AND A NITROGEN-FREE NONIONIC SURFACTANT HAVING OXYALKYLENE GROUPS BEROL KEMI AB (SW) 1977-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218633-A1 METHODS OF TREATING ORAL MUCOSITIS LPO, SOD3, MPO ALDH1A1 664/4885ALOX15 540/4885PKM 2522/4885
US-20230331919-A1 METHOD FOR PRODUCING HYDROPHILIC ORGANOPOLYSILOXANE GELS IDUA, HPSE, GAA ALDH1A1 779/4885ALOX15 2444/4885PKM 3352/4885
US-12370135-B2 Anhydrous composition for caring for and/or making up keratin materials KRT18, VIM, PLOD3 ALDH1A1 3185/4885ALOX15 228/4885PKM 1451/4885
US-11612608-B2 Methods of treating oral mucositis LPO, SOD3, MPO ALDH1A1 664/4885ALOX15 540/4885PKM 2522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.